Literature DB >> 23095775

Altered claudin-4 expression in progesterone-treated endometrial adenocarcinoma cell line Ishikawa.

Pan Xiao-Yu1, Jin Yan, Feng Cui-Ping, Wang Ya-Nan, Lin Hua, L Hua-Jun.   

Abstract

OBJECTIVE: To detect the expression change of claudin-4 in Ishikawa endometrial adenocarcinoma cell line in response to progesterone. To determine whether claudin-4 is involved in the anticancer effect of progesterone.
METHODS: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was used to determine the 50% inhibitory concentration (IC50) of megestrol acetate (MA) in treating Ishikawa cells. After the Ishikawa cells were treated with MA at IC50, cell apoptosis was examined by flow cytometry and transmission electron microscopy. The messenger RNA and protein expression levels of claudin-4 were further quantified by real-time polymerase chain reaction and Western blot. The localization of claudin-4 was examined by immunofluorescent staining.
RESULTS: The IC50 of MA on Ishikawa cells was 15 mg/L incubated for 72 hours. Apoptosis percentage was elevated from 0.07% ± 0.02% to 3.93% ± 0.81% after MA treatment. The expression of claudin-4 at both protein and messenger RNA levels was significantly decreased after the treatment of MA (P < 0.05). The localization of claudin-4 transferred from cytomembrane to cytoplasm and nucleus.
CONCLUSION: Megestrol acetate can inhibit the growth of Ishikawa cells. It may work through decreasing claudin-4 expression and cell apoptosis. The localization change of claudin-4 may also be involved in the anticancer effect of progesterone.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23095775     DOI: 10.1097/IGC.0b013e318272ab12

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  1 in total

1.  Role of Clostridium perfringens Enterotoxin on YAP Activation in Colonic Sessile Serrated Adenoma/ Polyps with Dysplasia.

Authors:  Rina Fujiwara-Tani; Kiyomu Fujii; Shiori Mori; Shingo Kishi; Takamitsu Sasaki; Hitoshi Ohmori; Chie Nakashima; Isao Kawahara; Yukiko Nishiguchi; Takuya Mori; Masayuki Sho; Masuo Kondoh; Yi Luo; Hiroki Kuniyasu
Journal:  Int J Mol Sci       Date:  2020-05-28       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.